2,3,4,5-Tetrahydroxypentyl dihydrogen phosphate (BioDeep_00000842861)

   


代谢物信息卡片


2,3,4,5-Tetrahydroxypentyl dihydrogen phosphate

化学式: C5H13O8P (232.0348028)
中文名称:
谱图信息: 最多检出来源 () 0%

分子结构信息

SMILES: C(C(C(C(COP(=O)(O)O)O)O)O)O
InChI: InChI=1S/C5H13O8P/c6-1-3(7)5(9)4(8)2-13-14(10,11)12/h3-9H,1-2H2,(H2,10,11,12)

描述信息

同义名列表

1 个代谢物同义名

2,3,4,5-Tetrahydroxypentyl dihydrogen phosphate



数据库引用编号

3 个数据库交叉引用编号

分类词条

相关代谢途径

Reactome(0)

BioCyc(0)

PlantCyc(0)

代谢反应

0 个相关的代谢反应过程信息。

Reactome(0)

BioCyc(0)

WikiPathways(0)

Plant Reactome(0)

INOH(0)

PlantCyc(0)

COVID-19 Disease Map(0)

PathBank(0)

PharmGKB(0)

0 个相关的物种来源信息

在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有:

  • PubMed: 来源于PubMed文献库中的文献信息,我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表,这个列表按照代谢物同时出现的文献数量降序排序,取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
  • NCBI Taxonomy: 通过文献数据挖掘,得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序,取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
  • Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
  • Chemical Reaction: 在化学反应过程中,存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。

点击图上的相关代谢物的名称,可以跳转到相关代谢物的信息页面。



文献列表

  • Gary S Marshall, Mark Blatter, Colin Marchant, Emmanuel Aris, Narcisa Mesaros, Jacqueline M Miller. Antibody persistence for up to 5 years after a fourth dose of Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine (HibMenCY-TT) given at 12-15 months of age. The Pediatric infectious disease journal. 2013 Jun; 32(6):662-8. doi: 10.1097/inf.0b013e3182840e35. [PMID: 23340564]
  • Naruhiko Ishiwada, Yoshiko Honda, Junko Tanaka, Haruka Hishiki, Yoichi Kohno. Anti-polyribosylribitol phosphate antibody in pediatric patients with Haemophilus influenzae type b invasive disease. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. 2011 Jun; 17(3):397-400. doi: 10.1007/s10156-010-0186-x. [PMID: 21188446]
  • Patricia Gómez-de-León, F Javier Díaz-García, Alberto Villaseñor-Sierra, Jorge Segura, Martha I Carranza, José Luis Arredondo-Garcia, José Ignacio Santos. Immunoglobulin G avidities in infants in Mexico after primary immunization with three doses of polyribosylribitol phosphate-tetanus toxoid Haemophilus influenzae type b vaccine. Clinical and vaccine immunology : CVI. 2008 Jun; 15(6):1024-7. doi: 10.1128/cvi.00009-08. [PMID: 18417667]
  • Felix Omeñaca, José Garcia-Sicilia, Pilar García-Corbeira, Reyes Boceta, Victorio Torres. Antipolyribosyl ribitol phosphate response of premature infants to primary and booster vaccination with a combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio virus/Haemophilus influenzae type b vaccine. Pediatrics. 2007 Jan; 119(1):e179-85. doi: 10.1542/peds.2005-2907. [PMID: 17145903]
  • Sandra Romero-Steiner, Patricia F Holder, Patricia Gomez de Leon, Willie Spear, Thomas W Hennessy, George M Carlone. Avidity determinations for Haemophilus influenzae Type b anti-polyribosylribitol phosphate antibodies. Clinical and diagnostic laboratory immunology. 2005 Sep; 12(9):1029-35. doi: 10.1128/cdli.12.9.1029-1035.2005. [PMID: 16148167]
  • Fatme Mawas, Marisa Peyre, Anne-Sophie Beignon, Laura Frost, Giuseppe Del Giudice, Rino Rappuoli, Sylviane Muller, Dorothea Sesardic, Charalambos D Partidos. Successful induction of protective antibody responses against Haemophilus influenzae type b and diphtheria after transcutaneous immunization with the glycoconjugate polyribosyl ribitol phosphate-cross-reacting material 197 vaccine. The Journal of infectious diseases. 2004 Sep; 190(6):1177-82. doi: 10.1086/423327. [PMID: 15319869]
  • D M Granoff. Assessing efficacy of Haemophilus influenzae type b combination vaccines. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2001 Dec; 33 Suppl 4(?):S278-87. doi: 10.1086/322563. [PMID: 11709760]
  • S Usen, P Milligan, C Ethevenaux, B Greenwood, K Mulholland. Effect of fever on the serum antibody response of Gambian children to Haemophilus influenzae type b conjugate vaccine. The Pediatric infectious disease journal. 2000 May; 19(5):444-9. doi: 10.1097/00006454-200005000-00010. [PMID: 10819341]
  • Shuichi Miyazaki, Tetsuya Matsumoto, Nobuhiko Furuya, Kazuhiro Tateda, Keizo Yamaguchi. The pathogenic role of fimbriae of Haemophilus influenzae type b in murine bacteraemia and meningitis. Journal of medical microbiology. 1999 Apr; 48(4):383-388. doi: 10.1099/00222615-48-4-383. [PMID: 10509481]
  • H Shams, I Heron. The effect of conjugation on immunogenicity and potency of protein carriers of polyribosylribitol phosphate (PRP) conjugated vaccines in the mouse model. APMIS : acta pathologica, microbiologica, et immunologica Scandinavica. 1998 May; 106(5):526-34. doi: 10.1111/j.1699-0463.1998.tb01380.x. [PMID: 9674889]
  • M Akkoyunlu, A Melhus, C Capiau, O van Opstal, A Forsgren. The acylated form of protein D of Haemophilus influenzae is more immunogenic than the nonacylated form and elicits an adjuvant effect when it is used as a carrier conjugated to polyribosyl ribitol phosphate. Infection and immunity. 1997 Dec; 65(12):5010-6. doi: 10.1128/iai.65.12.5010-5016.1997. [PMID: 9393790]
  • K M Bewley, J G Schwab, G A Ballanco, R S Daum. Interchangeability of Haemophilus influenzae type b vaccines in the primary series: evaluation of a two-dose mixed regimen. Pediatrics. 1996 Nov; 98(5):898-904. doi: NULL. [PMID: 8909483]
  • A E Agbarakwe, H Griffiths, N Begg, H M Chapel. Avidity of specific IgG antibodies elicited by immunisation against Haemophilus influenzae type b. Journal of clinical pathology. 1995 Mar; 48(3):206-9. doi: 10.1136/jcp.48.3.206. [PMID: 7730477]
  • R J Roche, E R Moxon. Phenotypic variation in Haemophilus influenzae: the interrelationship of colony opacity, capsule and lipopolysaccharide. Microbial pathogenesis. 1995 Feb; 18(2):129-40. doi: 10.1016/s0882-4010(95)90117-5. [PMID: 7643742]
  • H Brüssow, J Sidoti, H Dirren, W B Freire. Effect of malnutrition in Ecuadorian children on titers of serum antibodies to various microbial antigens. Clinical and diagnostic laboratory immunology. 1995 Jan; 2(1):62-8. doi: 10.1128/cdli.2.1.62-68.1995. [PMID: 7719915]
  • R Bunse, H P Heinz. Characterization of a monoclonal antibody to the capsule of Haemophilus influenzae type b, generated by in vitro immunization. Journal of immunological methods. 1994 Dec; 177(1-2):89-99. doi: 10.1016/0022-1759(94)90146-5. [PMID: 7822841]
  • H Brüssow, J Sidoti, A Rytz. Antibody response to polyribosyl-ribitol phosphate antigen of Haemophilus influenzae in Ecuadorian and German children. Clinical and diagnostic laboratory immunology. 1994 Jan; 1(1):21-5. doi: 10.1128/cdli.1.1.21-25.1994. [PMID: 7496916]
  • C C Peeters, D Evenberg, P Hoogerhout, H Käyhty, L Saarinen, C A van Boeckel, G A van der Marel, J H van Boom, J T Poolman. Synthetic trimer and tetramer of 3-beta-D-ribose-(1-1)-D-ribitol-5-phosphate conjugated to protein induce antibody responses to Haemophilus influenzae type b capsular polysaccharide in mice and monkeys. Infection and immunity. 1992 May; 60(5):1826-33. doi: 10.1128/iai.60.5.1826-1833.1992. [PMID: 1563770]
  • C Ferreccio, J Clemens, A Avendano, I Horwitz, C Flores, L Avila, M Cayazzo, B Fritzell, M Cadoz, M Levine. The clinical and immunologic response of Chilean infants to Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine coadministered in the same syringe with diphtheria-tetanus toxoids-pertussis vaccine at two, four and six months of age. The Pediatric infectious disease journal. 1991 Oct; 10(10):764-71. doi: 10.1097/00006454-199110000-00009. [PMID: 1945579]
  • J Langue, B Fritzell, M P Preziozi, P Houmeau. [Evaluation of the vaccination of 3-month-old infants with Haemophilus influenzae type B (Hi b) capsular polysaccharide conjugated to tetanus protein (PRT-T) Pediatric Group of the Lyon Region]. Pediatrie. 1991; 46(12):821-4. doi: NULL. [PMID: 1667038]
  • M Kuratana, E J Hansen, P Anderson. Multiple mechanisms in serum factor-induced resistance of Haemophilus influenzae type b to antibody. Infection and immunity. 1990 Apr; 58(4):914-9. doi: 10.1128/iai.58.4.914-919.1990. [PMID: 2318534]
  • D Scheifele, G L Bjornsen, T Arcand, K Jacobsen. Antigenuria after receipt of Haemophilus b diphtheria toxoid conjugate vaccine. The Pediatric infectious disease journal. 1989 Dec; 8(12):887-8. doi: 10.1097/00006454-198912000-00014. [PMID: 2626290]
  • M Kuratana, M R Loeb, E J Hansen, P Anderson. The antigenic specificity of a serum factor-induced phenotypic shift in Hemophilus influenzae type b, strain Eag. The Journal of infectious diseases. 1989 Jun; 159(6):1135-8. doi: 10.1093/infdis/159.6.1135. [PMID: 2470834]
  • W M McDonnell, J R Gilsdorf, J B Kent, J N Sheagren. Relationship of health-related variables to levels of anti-polyribosylribitol phosphate antibodies in adults. Journal of clinical microbiology. 1988 Jun; 26(6):1202-6. doi: 10.1128/jcm.26.6.1202-1206.1988. [PMID: 3260243]
  • M George, I van de Rijn. Nutritionally variant streptococcal serotype I antigen. Characterization as a lipid-substituted poly(ribitol phosphate). Journal of immunology (Baltimore, Md. : 1950). 1988 Mar; 140(6):2008-15. doi: . [PMID: 3279126]
  • A H Lucas. Expression of crossreactive idiotypes by human antibodies specific for the capsular polysaccharide of Hemophilus influenzae B. The Journal of clinical investigation. 1988 Feb; 81(2):480-6. doi: 10.1172/jci113345. [PMID: 3257499]
  • D Musher, A Goree, T Murphy, A Chapman, J Zahradnik, M Apicella, R Baughn. Immunity to Haemophilus influenzae type b in young adults: correlation of bactericidal and opsonizing activity of serum with antibody to polyribosylribitol phosphate and lipooligosaccharide before and after vaccination. The Journal of infectious diseases. 1986 Dec; 154(6):935-43. doi: 10.1093/infdis/154.6.935. [PMID: 3491165]
  • K Ramadas, G M Petersen, D C Heiner, J I Ward. Class and subclass antibodies to Haemophilus influenzae type b capsule: comparison of invasive disease and natural exposure. Infection and immunity. 1986 Sep; 53(3):486-90. doi: 10.1128/iai.53.3.486-490.1986. [PMID: 3488962]
  • S B Shurin, P Anderson, J Zollinger, R K Rathbun. Pathophysiology of hemolysis in infections with Hemophilus influenzae type b. The Journal of clinical investigation. 1986 Apr; 77(4):1340-8. doi: 10.1172/jci112439. [PMID: 3485660]
  • N Monji, M R Stebbins, D W McCoy, J S Kuo. Isolation of the outer membrane components of Bordetella pertussis which enhance the immunogenicity of Haemophilus influenzae type b capsular polysaccharide polyribosyl ribitol phosphate. Infection and immunity. 1986 Mar; 51(3):865-71. doi: 10.1128/iai.51.3.865-871.1986. [PMID: 2868992]
  • P G Shackelford, D M Granoff, M H Nahm, M G Scott, B Suarez, S J Nelson. Correlation of serum immunoglobulin subclass concentrations with antibody responses of children to immunization with Haemophilus influenzae type b polysaccharide-pertussis vaccine. Journal of clinical immunology. 1985 Nov; 5(6):390-5. doi: 10.1007/bf00915336. [PMID: 3878849]
  • J S Kuo, V W Doelling, J F Graveline, D W McCoy. Evidence for covalent attachment of phospholipid to the capsular polysaccharide of Haemophilus influenzae type b. Journal of bacteriology. 1985 Aug; 163(2):769-73. doi: 10.1128/jb.163.2.769-773.1985. [PMID: 3926752]
  • A B Macone, G Arakere, J M Letourneau, D A Goldmann. Comparison of a new, rapid enzyme-linked immunosorbent assay with latex particle agglutination for the detection of Haemophilus influenzae type b infections. Journal of clinical microbiology. 1985 May; 21(5):711-4. doi: 10.1128/jcm.21.5.711-714.1985. [PMID: 3889043]
  • D M Granoff, E G Boies, R S Munson. Immunogenicity of Haemophilus influenzae type b polysaccharide--diphtheria toxoid conjugate vaccine in adults. The Journal of pediatrics. 1984 Jul; 105(1):22-7. doi: 10.1016/s0022-3476(84)80350-9. [PMID: 6610736]
  • M F Tosi, S L Kaplan, E O Mason, G J Buffone, D C Anderson. Generation of chemotactic activity in serum by Haemophilus influenzae type b. Infection and immunity. 1984 Feb; 43(2):593-9. doi: 10.1128/iai.43.2.593-599.1984. [PMID: 6607218]
  • G Henne, F W Tiller, E Diener. Quantitation of Haemophilus influenzae serotype b capsular polysaccharide antigen in body fluids by enzyme immunoassay. Biomedica biochimica acta. 1984; 43(3):381-7. doi: NULL. [PMID: 6378194]
  • R Russell, F Mather, G Siber, G Rosenberg, R Daum. Value of antigen quantitation in Haemophilus influenzae type b meningitis. The Journal of pediatrics. 1984 Jan; 104(1):23-8. doi: 10.1016/s0022-3476(84)80583-1. [PMID: 6690672]
  • J L Shenep, R S Munson, S J Barenkamp, D M Granoff. Further studies of the role of noncapsular antibody in protection against experimental Haemophilus influenzae type b bacteremia. Infection and immunity. 1983 Oct; 42(1):257-63. doi: 10.1128/iai.42.1.257-263.1983. [PMID: 6604698]
  • N A Halsey, T L Johansen, L C Bowman, M P Glode. Evaluation of the protective efficacy of Haemophilus influenzae type b vaccines in an animal model. Infection and immunity. 1983 Mar; 39(3):1196-200. doi: 10.1128/iai.39.3.1196-1200.1983. [PMID: 6601621]
  • J Armand. [Prospects for the vaccinal prevention of Haemophilus influenzae type b meningitis]. Pathologie-biologie. 1983 Feb; 31(2):144-8. doi: NULL. [PMID: 6341945]
  • M E Pichichero, R A Insel. Relationship between naturally occurring human mucosal and serum antibody to the capsular polysaccharide of Haemophilus influenzae type b. The Journal of infectious diseases. 1982 Aug; 146(2):243-8. doi: 10.1093/infdis/146.2.243. [PMID: 6980956]
  • R S Daum, G R Siber, J S Kamon, R R Russell. Evaluation of a commercial latex particle agglutination test for rapid diagnosis of Haemophilus influenzae type b infection. Pediatrics. 1982 Apr; 69(4):466-71. doi: NULL. [PMID: 6978478]